Blueberry Therapeutics Ltd. is a modern drug discovery and development company which puts people first whether patients, employees, investors or partners. We have created an open, imaginative and fun team environment with a very serious objective: to create new, safer and effective medicines to treat human and companion animal disease and make patients feel better.
The Blueberry team has extensive experience in drug discovery and development and taking ideas and concepts all the way through to regulatory approval.
Blueberry is committed to the development of innovative therapies to treat diseases where infection and/or inflammation are major factors. We employ cutting-edge nanopolymer drug delivery technology, which enables us to exploit both small molecule and biologic approaches in developing treatments. Our portfolio includes a number of different programmes in the areas of infection and inflammation where there is a high unmet medical need.
Blueberry Therapeutics site located within the BioHub at Alderley Park